Share of Brooks Laboratories Limited is currently trading at around Rs.59/-. Existing as well as prospective Investors are asking for Brooks Laboratories Share Price Target 2026,2030,2035,2040. In this article, we will discuss about the business prospects and financial performance of the Company and based on our discussion and analysis will tell you the Brooks Laboratories Share Price Target 2026,2030,2035,2040.
Discussion and Business & Financial Analysis of Brooks Laboratories Ltd:
Brooks Laboratories Ltd currently operates as a small-cap pharmaceutical company with a market capitalization of about ₹213 crore. As of April 2026, promoters hold a stable 52.62% stake with no pledged shares, while mutual funds own 9.9% and retail investors account for 37.39%. The company faces challenges in profitability but shows modest revenue growth and potential upside in niche formulations.
Current Business Position
- Industry: Pharmaceuticals & Biotechnology (small-cap segment).
- Market Cap: ~₹213 crore (April 2026).
- Financial Performance:
- Revenue Growth: 3.9% YoY in FY-2025, slightly above its 5-year CAGR of 3.5%.
- Profitability: Net profit margin at 3.7%, operating profit margin only 1.7%.
- ROE: 3.31%; ROCE: 4.35% – relatively weak compared to industry peers.
- Stock Performance: Price at ₹72.3, down nearly 49% in the past year, reflecting investor caution.
Valuation Metrics:
- P/E ratio: 32.46 (suggests overvaluation relative to earnings).
- Price-to-book: 1.77.
- EV/EBITDA: 23.47 – indicates stretched valuations given modest earnings.
Future Business Prospects:
- Growth Drivers:
- Focus on contract manufacturing and niche formulations in the pharmaceutical sector.
- Potential to expand exports and partnerships with larger pharma companies.
- Rising demand for affordable generics in India and emerging markets could provide opportunities.
- Challenges:
- Low margins and weak operating efficiency remain a concern.
- Limited scale compared to mid-cap and large-cap pharma peers.
- Stock has delivered a negative CAGR (-0.1%) over the past 9 years, highlighting long-term underperformance.
Outlook:
- Short-term price trend analysis suggests strong momentum, indicating possible recovery in the near term.
- Sustained improvement in operating profit margins and scaling up production will be critical for long-term growth.
Promoters’ Shareholding
- Promoter Holding: 52.62% (unchanged across recent quarters).
- Pledge Status: 0% pledged – indicates strong governance and financial discipline.
- Institutional Investors:
- Mutual Funds: 9.9% (stable).
- FIIs: Increased slightly from 0.09% to 0.17% in March 2026.
- Retail Investors: 37.39% – significant retail participation, reflecting small-cap investor interest.
Key Takeaways:
- Strengths: Stable promoter holding, no pledged shares, modest revenue growth, potential in niche pharma segments.
- Weaknesses: Low profitability, small scale, high valuation relative to earnings, long-term underperformance.
- Future Path: Brooks Laboratories must improve operational efficiency, expand its product pipeline, and leverage partnerships to strengthen its position in the competitive pharmaceutical landscape.
Share Price Targets:
Brooks Laboratories Share Price Target 2026
Based on the above discussion and analysis, the share price of Brooks Laboratories Limited may touch the level of around Rs.70-75 in 2026
Brooks Laboratories Share Price Target 2030
Based on the above discussion and analysis, the share price of Brooks Laboratories Limited may touch the level of around Rs.140-150 in 2030
Brooks Laboratories Share Price Target 2035
Based on the above discussion and analysis, the share price of Brooks Laboratories Limited may touch the level of around Rs.300-350 in 2035
Brooks Laboratories Share Price Target 2040
Based on the above discussion and analysis, the share price of Brooks Laboratories Limited may touch the level of around Rs.700-750 in 2040
Disclaimer: Investment in Capital Market/Share Prices are subject to market fluctuations and are dependent on several factors. These predictions are based on the current market conditions and the future market expectations. Investors are advised to take into consideration all these factors before making any investment in Capital Market. This article should not be treated as Investment advisory and is for general Guidance & Educational purpose only. We keep revising our share price targets based on the latest information available with us. Please keep visiting our website regularly to keep yourself updated. MoneyInsight does not offer investment advice and does not encourage any action based on its content.
Read Also:
How to make maximum profit with minimum investment from the Stock Market ? – MoneyInsight
Also Read :
How to make money from share market? (indiatimes.com)
Visit our another Group Website regularly for more such Educational Research Articles:
How to make maximum profit with minimum investment from the Stock Market ? – MoneyInsight
Visit & Subscribe our Devotional Music Channel on YouTube:
Indian Devotional Music – YouTube
Visit our Website regularly for more such Educational Research Articles:
MoneyInsight – We Provide Insight to Your Money
